Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Bar Harbor Bankshares
BHB
$667M
| $987K | ﹤0.01% |
38,865
+1,665
| +4% | +$42.4K |
|
2602
Donegal Group Class A
DGICA
$693M
| $986K | ﹤0.01% |
66,471
-2,783
| -4% | -$40.7K |
|
|
ACBI
2603
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $984K | ﹤0.01% |
53,579
-1,378
| -3% | -$25.3K |
|
|
FPRX
2604
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $973K | ﹤0.01% |
211,854
-5,992
| -3% | -$23.7K |
|
2605
Entravision Communication
EVC
$850M
| $968K | ﹤0.01% |
369,109
-4,369
| -1% | -$11.9K |
|
2606
NI Holdings
NODK
$315M
| $968K | ﹤0.01% |
56,231
+660
| +1% | +$11.3K |
|
2607
Atlassian
TEAM
$39.1B
| $967K | ﹤0.01% |
8,034
-317
| -4% | -$38.6K |
|
2608
Ring Energy
REI
$357M
| $966K | ﹤0.01% |
365,798
+21,104
| +6% | +$41.4K |
|
|
PZN
2609
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $965K | ﹤0.01% |
111,884
+1,257
| +1% | +$10.8K |
|
|
ORC
2610
Orchid Island Capital
ORC
$1.31B
| $960K | ﹤0.01% |
32,817
| – | – |
|
2611
Universal Logistics Holdings
ULH
$503M
| $957K | ﹤0.01% |
50,439
-1,711
| -3% | -$35.7K |
|
|
RST
2612
DELISTED
ROSETTA STONE INC
RST
| $957K | ﹤0.01% |
52,708
+1,293
| +3% | +$22K |
|
2613
Alpha Metallurgical Resources
AMR
$1.95B
| $952K | ﹤0.01% |
105,146
-10,232
| -9% | -$156K |
|
2614
XBiotech
XBIT
$71M
| $951K | ﹤0.01% |
50,941
+5,176
| +11% | +$66.6K |
|
2615
Wave Life Sciences
WVE
$993M
| $950K | ﹤0.01% |
118,445
+2,481
| +2% | +$60.8K |
|
|
NOVA
2616
DELISTED
Sunnova Energy
NOVA
| $949K | ﹤0.01% |
84,949
+8,214
| +11% | +$85.6K |
|
2617
Bloom Energy
BE
$62.2B
| $941K | ﹤0.01% |
125,888
+5,032
| +4% | +$24.4K |
|
2618
Utah Medical Products
UTMD
$229M
| $941K | ﹤0.01% |
8,712
| – | – |
|
|
ARA
2619
DELISTED
American Renal Associates Holdings, Inc
ARA
| $937K | ﹤0.01% |
90,321
+990
| +1% | +$8.47K |
|
|
DSSI
2620
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $934K | ﹤0.01% |
55,742
-1,452
| -3% | -$21.7K |
|
|
CASI
2621
DELISTED
CASI Pharmaceuticals
CASI
| $929K | ﹤0.01% |
30,054
+2,697
| +10% | +$87.5K |
|
2622
Ardelyx
ARDX
$982M
| $927K | ﹤0.01% |
123,486
+10,696
| +9% | +$65K |
|
2623
PagerDuty
PD
$915M
| $927K | ﹤0.01% |
39,600
+2,897
| +8% | +$71.2K |
|
|
REV
2624
DELISTED
Revlon, Inc.
REV
| $927K | ﹤0.01% |
43,233
+889
| +2% | +$21.4K |
|
|
AFMD
2625
DELISTED
Affimed
AFMD
| $925K | ﹤0.01% |
33,727
+3,093
| +10% | +$82.7K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.